Simple stent may cut pancreatic leak risk after major surgery
NCT ID NCT06743516
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study tests whether placing a small tube (stent) in the pancreas during Whipple surgery can prevent a common complication called pancreatic fistula, where digestive fluid leaks out. The trial will compare 100 patients with a soft pancreas who either get the stent or not. The goal is to see which approach leads to fewer leaks and better recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ureteric stent used as external pancreatic drain
- What this could lead to
- If successful, this could provide a simple way to lower the risk of pancreatic fistula after Whipple surgery, improving recovery for patients with a soft pancreas.
- What could go wrong
- This is a small, single-center trial with 100 participants, so results may not apply to all patients. The procedure itself carries surgical risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPULLARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Liver and GIT hospital , Minia University
RECRUITINGMinya, 61519, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?
- Can a pill rouse the immune system against pancreatic cancer?